Related Experiment Video

Updated: Apr 8, 2026

Solid-phase Synthesis of [4.4] Spirocyclic Oximes
05:15

Solid-phase Synthesis of [4.4] Spirocyclic Oximes

Published on: February 6, 2019

7.4K

Comparative determination of the efficacy of bispyridinium oximes in paraoxon poisoning

Suzana Žunec, Božica Radić, Kamil Kuča

    Arhiv Za Higijenu Rada I Toksikologiju
    |June 26, 2015
    PubMed

    Insights

    New K-oximes offer improved protection against organophosphorus poisoning. K027 and K048 demonstrated low toxicity and high efficacy, suggesting their potential as effective antidotes for paraoxon intoxication.

    Area of Science:

    • Toxicology
    • Pharmacology
    • Medicinal Chemistry

    Background:

    • Standard therapies for organophosphorus compound poisoning, including pesticides and nerve agents, are often inadequate.
    • There is a critical need for novel oximes with enhanced efficacy and safety profiles.

    Purpose of the Study:

    • To evaluate the pharmacotoxicological properties and therapeutic efficacy of six experimental K-oximes.
    • To compare the efficacy of novel K-oximes against established oximes (HI-6 and TMB-4) in treating paraoxon poisoning.

    Main Methods:

    • In vivo assessment of six K-oximes (K027, K033, K048, K074, K075, K203) in mice.
    • Determination of LD50 values for K-oximes and assessment of therapeutic efficacy when combined with atropine in paraoxon-poisoned mice.
    • Comparative analysis with HI-6 and TMB-4.

    Main Results:

    • K074 exhibited the highest toxicity (LD50=21.4 mg/kg), while K027 showed the lowest (LD50=672.8 mg/kg).
    • Except for K033, all tested K-oximes outperformed HI-6 and TMB-4 in therapeutic efficiency.
    • K027 and K048 demonstrated significant protective indices (60.0-100.0 LD50 of paraoxon) with low acute toxicity.

    Conclusions:

    • K027 and K048 possess favorable safety and efficacy profiles for treating paraoxon intoxication.
    • These K-oximes show potential as superior antidotes compared to current treatments.
    • Further investigation into K027 and K048 is warranted for clinical application against organophosphorus poisoning.

    More Related Videos

    Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

    Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

    Published on: February 9, 2021

    2.1K
    Protocols for Testing the Toxicity of Novel Insecticidal Chemistries to Mosquitoes09:32

    Protocols for Testing the Toxicity of Novel Insecticidal Chemistries to Mosquitoes

    Published on: February 13, 2019

    16.6K

    Related Concept Videos

    Anticholinesterase Agents: Poisoning and Treatment01:26

    Anticholinesterase Agents: Poisoning and Treatment

    Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
    Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
    2.0K
    Pharmaceutical Poisoning: Treatment Strategies01:26

    Pharmaceutical Poisoning: Treatment Strategies

    Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
    186
    Enhanced Elimination of Poison01:26

    Enhanced Elimination of Poison

    Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
    Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
    Renal excretion is the...
    1.0K
    Depolarizing Blockers: Pharmocokinetics01:19

    Depolarizing Blockers: Pharmocokinetics

    Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
    729
    Toxidromes: Clinical Features01:30

    Toxidromes: Clinical Features

    Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
    134
    Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

    Indirect-Acting Cholinergic Agonists: Mechanism of Action

    Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
    Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
    3.0K